Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
Mandana Nikpour, Pravin Hissaria, Jillian Byron, Joanne Sahhar, Maree Micallef, William Paspaliaris, Janet Roddy, Peter Nash, Alan Sturgess, Susanna Proudman, Wendy Stevens
ARTHRITIS RESEARCH & THERAPY | BMC | Published : 2011
Financial support for the present study was provided by a University of Melbourne Early Career Researcher Grant (to MN), Scleroderma Australia, Arthritis Australia, Actelion Australia, Bayer, CSL Biotherapies, GlaxoSmithKline Australia, and Pfizer. The authors also wish to thank St Vincent's Hospital Melbourne Information Technology Department for their expert advice and continued support of the Australian Scleroderma Cohort Study and Database.